What question did this study set out to answer?

To compare the scientific dissemination of gene therapy publications for sickle cell disease, hemophilia, and thalassemia.

December 8, 2025BloodOpen Access

Gene therapy in three classical hematological disorders – is social media making a difference?

View Full Paper

Ask AI

Bookmark

Authors

Altmetric scores reveal social media shapes clinical awareness and research engagement in gene therapy across blood disorders.

To compare the scientific dissemination of gene therapy publications for sickle cell disease, hemophilia, and thalassemia.
PubMed search for gene therapy trials from 2015 to 2025
Calculated citations using Google Scholar metrics
Determined Altmetric scores via www.altmetric.com
Reported median and range statistics
Used Kruskal-Wallis test for group comparison
SCD had the highest median citations (147), followed by hemophilia (26) and thalassemia (42)
Altmetric scores indicated SCD’s median was 422, with Twitter as the primary engagement platform
Scholarly interest measured by Mendeley readers was highest for SCD, with median 195

Richard C. Godby (2025) studied this question.

View Full Paper

Ask AI

Bookmark